Kevin J. Milliner

1.1k citations

13 papers · 892 indexed · h-index 11

Cancer Research top 10%
Biochemistry top 10%
Surgery top 10%
- Lipoproteins and Cardiovascular Health 3
Clinical Biochemistry top 10%
- Paraoxonase enzyme and polymorphisms 2
Endocrinology, Diabetes and Metabolism top 10%
Molecular Biology
- Protein Kinase Regulation and GTPase Signaling 6
- Biochemical and Molecular Research 3
- Cell death mechanisms and regulation 2
Genetics
- Blood disorders and treatments 4
- Chronic Lymphocytic Leukemia Research 2
Cardiology and Cardiovascular Medicine
- Lipid metabolism and disorders 2

Co-authors: Colin H. Macphee Robert J. Ife David G. Tew Colin A. Leach Deirdre M. B. Hickey Kitty Moores Helen Boyd Rebecca A. Patterson
Cited by: Cancer Research Biochemistry Surgery
Journals: Biochemical Journal (2 papers)Journal of Medicinal Chemistry (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)
Partner nations: United Kingdom United States Canada

In The Last Decade

Kevin J. Milliner

13 papers receiving 865 citations

Peers

Countries citing papers authored by Kevin J. Milliner

Since Specialization

Citations

This map shows the geographic impact of Kevin J. Milliner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin J. Milliner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin J. Milliner more than expected).

Fields of papers citing papers by Kevin J. Milliner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin J. Milliner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin J. Milliner. The network helps show where Kevin J. Milliner may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kevin J. Milliner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kevin J. Milliner Line = papers co-authored together Kevin J. Milliner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work
1	Characterisation of the lipoprotein structure in the St. Thomas’ Mixed Hyperlipidaemic (SMHL) rabbit Atherosclerosis ·Baukje de Roos,Muriel Caslake,Kevin J. Milliner,G. Martin Benson,Keith E. Suckling,Chris J. Packard	2005	4
2	The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2 Bioorganic & Medicinal Chemistry Letters ·Josie A. Blackie,Jackie C. Bloomer,Murray J. B. Brown,Hung‐Yuan Cheng,Beverley Hammond,Deirdre M. B. Hickey,Robert J. Ife,Colin A. Leach,Vahn A. Lewis,Colin H. Macphee,Kevin J. Milliner,Kitty Moores,Ivan L. Pinto,Stephen A. Smith,Ian Stansfield,Steven J. Stanway,Maxine Taylor,Colin J. Theobald	2003	100
3	Potent, orally active inhibitors of lipoprotein-associated phospholipase A2: 1-(biphenylmethylamidoalkyl)-pyrimidones Bioorganic & Medicinal Chemistry Letters ·Helen Boyd,Stephen C. M. Fell,Deirdre M. B. Hickey,Robert J. Ife,Colin A. Leach,Colin H. Macphee,Kevin J. Milliner,Ivan L. Pinto,D. Anthony Rawlings,Stephen A. Smith,Ian Stansfield,Steven J. Stanway,Colin J. Theobald,Caroline Whittaker	2002	25
4	The discovery of SB-435495 Bioorganic & Medicinal Chemistry Letters ·Josie A. Blackie,Jackie C. Bloomer,Murray J. B. Brown,Hung‐Yuan Cheng,Richard L. Elliott,Beverley Hammond,Deirdre M. B. Hickey,Robert J. Ife,Colin A. Leach,Vahn A. Lewis,Colin H. Macphee,Kevin J. Milliner,Kitty Moores,Ivan L. Pinto,Stephen A. Smith,Ian Stansfield,Steven J. Stanway,Maxine Taylor,Colin J. Theobald,Caroline Whittaker	2002	34
5	The identification of a potent, water soluble inhibitor of lipoprotein-associated phospholipase A2 Bioorganic & Medicinal Chemistry Letters ·Helen Boyd,Beverley Hammond,Deirdre M.B. Hickey,Robert J. Ife,Colin A. Leach,Vahn A. Lewis,Colin H. Macphee,Kevin J. Milliner,Ivan L. Pinto,Stephen A. Smith,Ian Stansfield,Colin J. Theobald,Caroline Whittaker	2001	8
6	1-(Arylpiperazinylamidoalkyl)-pyrimidones: orally active inhibitors of lipoprotein-associated phospholipase A 2 Bioorganic & Medicinal Chemistry Letters ·Jackie C. Bloomer,Helen Boyd,Deirdre M.B. Hickey,Robert J. Ife,Colin A. Leach,Colin H. Macphee,Kevin J. Milliner,Ivan L. Pinto,D. Anthony Rawlings,Stephen A. Smith,Ian Stansfield,Steven J. Stanway,Maxine Taylor,Colin J. Theobald,Caroline Whittaker	2001	13
7	N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2 Bioorganic & Medicinal Chemistry Letters ·Helen Boyd,Stephen C. M. Fell,Sean T. Flynn,Deirdre M. B. Hickey,Robert J. Ife,Colin A. Leach,Colin H. Macphee,Kevin J. Milliner,Kitty Moores,Ivan L. Pinto,Rod A. Porter,D. Anthony Rawlings,Stephen A. Smith,Ian Stansfield,David G. Tew,Colin J. Theobald,Caroline Whittaker	2000	24
8	2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A2 Bioorganic & Medicinal Chemistry Letters ·Helen Boyd,Sean T. Flynn,Deirdre M.B. Hickey,Robert J. Ife,Martin Jones,Colin A. Leach,Colin H. Macphee,Kevin J. Milliner,D. Anthony Rawlings,Brian P. Slingsby,Stephen A. Smith,Ian Stansfield,David G. Tew,Colin J. Theobald	2000	17
9	Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor Biochemical Journal ·Colin H. Macphee,Kitty Moores,Helen Boyd,Dash Dhanak,Robert J. Ife,Colin A. Leach,David S. Leake,Kevin J. Milliner,Rebecca A. Patterson,Keith E. Suckling,David G. Tew,Deirdre M. B. Hickey	1999	296
10	Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor Biochemical Journal ·Colin H. Macphee,Kitty Moores,Helen Boyd,Dash Dhanak,Robert J. Ife,Colin A. Leach,David S. Leake,Kevin J. Milliner,Rebecca A. Patterson,Keith E. Suckling,David G. Tew,Deirdre M. B. Hickey	1999	73
11	Lipoprotein-Associated Phospholipase A ₂ , Platelet-Activating Factor Acetylhydrolase, Is Expressed by Macrophages in Human and Rabbit Atherosclerotic Lesions Arteriosclerosis Thrombosis and Vascular Biology ·Tomi Häkkinen,Jukka Luoma,Mikko Hiltunen,Colin H. Macphee,Kevin J. Milliner,Lisa Patel,Simon Q.J. Rice,David G. Tew,Kari Karkola,Seppo Ylä‐Herttuala	1999	203
12	Purine derivatives as competitive inhibitors of human erythrocyte membrane phosphatidylinositol 4-kinase Journal of Medicinal Chemistry ·Rodney C. Young,Martin Jones,Kevin J. Milliner,Kishore K. Rana,John G. Ward	1990	30
13	Studies on the mechanism of action of omeprazole Biochemical Pharmacology ·David J. Keeling,Colin Fallowfield,Kevin J. Milliner,Stephen K. Tingley,Robert J. Ife,Anthony H. Underwood	1985	65

About Kevin J. Milliner

Kevin J. Milliner is a scholar working on Clinical Biochemistry, Physiology and Genetics, having authored 13 papers that have together received 892 indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (6 papers), Blood disorders and treatments (4 papers), Biochemical and Molecular Research (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Cell death mechanisms and regulation (2 papers), Lipid metabolism and disorders (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Paraoxonase enzyme and polymorphisms (2 papers). The work is most often cited by research in Cancer Research (263 citations), Biochemistry (67 citations) and Surgery (449 citations). Kevin J. Milliner has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Colin H. Macphee, Robert J. Ife, David G. Tew, Colin A. Leach, Deirdre M. B. Hickey, Kitty Moores, Helen Boyd, Rebecca A. Patterson, David S. Leake and Keith E. Suckling. Their work appears in journals such as Biochemical Journal, Journal of Medicinal Chemistry and Arteriosclerosis Thrombosis and Vascular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact